Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03147846
Other study ID # milking vs delayed clamping
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 8, 2017
Est. completion date September 1, 2019

Study information

Verified date March 2020
Source Zagazig University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Comparing the beneficial effect of cord milking versus deferred cord clamping in preterm neonates. A randomized controlled trial


Description:

Placental transfusion either by deferred cord clamping or umbilical cord milking became standard care and recommended management especially in preterm deliveries.1 In average, about 80 ml of blood was found to be transferred to the neoborn by one minute after birth.2 This additional blood can afford extra iron and blood volume giving the benefit of less iron deficiency anemia during the first year of life, less need for blood transfusion, less need for vasopressors and less intraventricular hemorrhage (IVH) by 50%.3 Placental transfusion with different techniques proved safety with no significant risks regarding postpartum hemorrhage, polycythemia, jaundice, Apgar score or admission rates.4 Our study aims to compare delayed cord clamping with umbilical cord milking as the best way for placental transfusion for preterm neonates.


Recruitment information / eligibility

Status Completed
Enrollment 200
Est. completion date September 1, 2019
Est. primary completion date September 1, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 24 Weeks to 35 Weeks
Eligibility Inclusion Criteria:

• Gestational age 24 to 34+6 weeks

Exclusion Criteria:

- Category III CTG

- Monochorionic twins

- Significant antepartum hemorrhage

- IUGR or Rh incompatibility

Study Design


Intervention

Procedure:
delayed cord clamping
delay of cord clamping for 60 seconds
cord milking
active cord milking 5 times

Locations

Country Name City State
Saudi Arabia Armed Forces Hospital of Southern Region Khamis Mushait

Sponsors (2)

Lead Sponsor Collaborator
Zagazig University Armed Forces Hospitals, Southern Region, Saudi Arabia

Country where clinical trial is conducted

Saudi Arabia, 

Outcome

Type Measure Description Time frame Safety issue
Primary hematological parameters of the premature neonates first draw and peak hematocrit value and hemoglobin percent, need for inotropes and blood transfusion 12 months
Secondary composite neonatal morbidities incidence of intraventricular hemorrhage, necrotizing enterocolitis, retinopathy, jaundice, sepsis , patent ductus arteriosus, etc 12 month
See also
  Status Clinical Trial Phase
Completed NCT05957900 - Neurobehavioral Responses to Multisensory Stimulation Module in Preterm Neonates N/A
Completed NCT06173622 - Effects of Fetal Positioning During Venipuncture N/A
Completed NCT04122300 - Euphrasia Eye Drops in Preterm Infants With First Signs of Congestion of Nasolacrimal Duct Phase 3
Recruiting NCT02798926 - Polyethylene Bag: a Way of Preventing Hypothermia During Central Venous Catheter Placement in Preterm Neonates? N/A
Withdrawn NCT02853253 - Rate of Bronchopulmonary Dysplasia in Preterms Neonates: a Trial Comparing SMOFlipid and Medialipide Phase 4
Completed NCT01215591 - Trial of Weaning of Nasal Continuous Positive Airway Pressure (CPAP) N/A
Completed NCT05892081 - Colloidal Oatmeal, Colloid Cream, Diaper Rash, Preterm Neonates and Neonatal Intensive Care Unit Phase 4